Hedges Asset Management’s Amneal Pharmaceuticals AMRX Stock Holding History

Hedges Asset Management’s Portfolio AMRX Stock Details AMRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-50,000	Closed	-$303K	–	112
2024 Q1	$303K	Sell	50,000 -34,600	-41%	-$195K	0.21%	89
2023 Q4	$514K	Hold	84,600	–	–	0.4%	63
2023 Q3	$357K	Hold	84,600	–	–	0.31%	76
2023 Q2	$262K	Hold	84,600	–	–	0.22%	91
2023 Q1	$118K	Buy	84,600 +34,600	+69%	+$68.9K	0.1%	102
2022 Q4	$99.5K	Sell	50,000 -25,000	-33%	-$56K	0.09%	105
2022 Q3	$152K	Hold	75,000	–	–	0.15%	99
2022 Q2	$239K	Hold	75,000	–	–	0.23%	88
2022 Q1	$313K	Hold	75,000	–	–	0.24%	92
2021 Q4	$359K	Buy	+75,000	New	+$374K	0.28%	87

Other funds holding AMRX

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

Fosun International Hong Kong, China $446M AUM 13.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Hedges Asset Management's AMRX Position: Q2 2024 in Review

Hedges Asset Management sold out of Amneal Pharmaceuticals (AMRX) in Q2 2024, closing a stake of 50,000 shares — an estimated $303K sold.

Hedges Asset Management first reported a position in AMRX in Q4 2021 and held it in 10 quarters. The position peaked at $514K in Q4 2023. 181 funds tracked by Wall St. Rank hold AMRX as of Q2 2024.

Hedges Asset Management reported no remaining Amneal Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
Hedges Asset Management sold 50,000 Amneal Pharmaceuticals shares in Q2 2024, an estimated $303K.
Hedges Asset Management first reported a position in Amneal Pharmaceuticals in Q4 2021 and held it in 10 quarters.
Hedges Asset Management's Amneal Pharmaceuticals position peaked at $514K in Q4 2023.
181 funds tracked by Wall St. Rank held Amneal Pharmaceuticals as of Q2 2024.

Based on Hedges Asset Management's 13F filing for Q2 2024, filed 19 Jul 2024.